These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 9779246

  • 21. Heparan sulfate proteoglycan from human tubular basement membrane. Comparison with this component from the glomerular basement membrane.
    van den Heuvel LP, van den Born J, Veerkamp JH, van de Velden TJ, Schenkels L, Monnens LA, Schröder CH, Berden JH.
    Biochim Biophys Acta; 1990 Jun 11; 1025(1):67-76. PubMed ID: 2164419
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of serum properdin levels and properdin deposition in the dermal-epidermal junction in systemic lupus erythematosus.
    Schrager MA, Rothfield NF.
    J Clin Invest; 1976 Jan 11; 57(1):212-21. PubMed ID: 1245600
    [Abstract] [Full Text] [Related]

  • 23. Mouse mammary epithelial cells produce basement membrane and cell surface heparan sulfate proteoglycans containing distinct core proteins.
    Jalkanen M, Rapraeger A, Bernfield M.
    J Cell Biol; 1988 Mar 11; 106(3):953-62. PubMed ID: 2964452
    [Abstract] [Full Text] [Related]

  • 24. Immunoglobulin in clinically uninvolved skin in systemic lupus erythematosus: association with renal disease.
    Gilliam JN, Cheatum DE, Hurd ER, Stastny P, Ziff M.
    J Clin Invest; 1974 May 11; 53(5):1434-40. PubMed ID: 4596508
    [Abstract] [Full Text] [Related]

  • 25. Immunoglobulin deposits in skin in systemic lupus erythematosus.
    Wierzchowiecki MO, Quismorio FP, Friou GJ.
    Arthritis Rheum; 1975 May 11; 18(1):77-82. PubMed ID: 163639
    [Abstract] [Full Text] [Related]

  • 26. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations.
    Termaat RM, Brinkman K, Nossent JC, Swaak AJ, Smeenk RJ, Berden JH.
    Clin Exp Immunol; 1990 Nov 11; 82(2):268-74. PubMed ID: 2242607
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Skin basement membrane immunofluorescence in rheumatoid arthritis: lack of diagnostic correlation.
    DeBoer DC, Moskowitz RW, Michel B.
    Arthritis Rheum; 1977 Mar 11; 20(2):653-6. PubMed ID: 322669
    [Abstract] [Full Text] [Related]

  • 29. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate.
    van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH.
    Lab Invest; 1991 Sep 11; 65(3):287-97. PubMed ID: 1890809
    [Abstract] [Full Text] [Related]

  • 30. Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.
    Kashihara N, Makino H, Szekanecz Z, Waltenbaugh CR, Kanwar YS.
    Lab Invest; 1992 Dec 11; 67(6):752-60. PubMed ID: 1460866
    [Abstract] [Full Text] [Related]

  • 31. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
    Rops AL, van den Hoven MJ, Bakker MA, Lensen JF, Wijnhoven TJ, van den Heuvel LP, van Kuppevelt TH, van der Vlag J, Berden JH.
    Nephrol Dial Transplant; 2007 Jul 11; 22(7):1891-902. PubMed ID: 17550924
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibodies to heparan sulfate proteoglycan: development and application to the study of normal tissue and pathologic human kidney biopsies.
    Kemeny E, Fillit HM, Damle S, Mahabir R, Kefalides NA, Gregory JD, Antonovych T, Sabnis S, Zabriskie JB.
    Connect Tissue Res; 1988 Jul 11; 18(1):9-25. PubMed ID: 2972530
    [Abstract] [Full Text] [Related]

  • 33. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane.
    Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH.
    Diabetologia; 1994 Mar 11; 37(3):313-20. PubMed ID: 8174847
    [Abstract] [Full Text] [Related]

  • 34. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE.
    Am J Nephrol; 2015 Mar 11; 41(3):241-7. PubMed ID: 25926050
    [Abstract] [Full Text] [Related]

  • 35. Isolation and immunochemical characterization of heparan sulfate rich proteoglycan (HSPG) present in the basement membrane of human placenta.
    Onodera S, Sasaki T, Tashiro S.
    Biol Pharm Bull; 1997 Feb 11; 20(2):113-7. PubMed ID: 9057969
    [Abstract] [Full Text] [Related]

  • 36. Glomerular heparan sulfate alterations: mechanisms and relevance for proteinuria.
    Raats CJ, Van Den Born J, Berden JH.
    Kidney Int; 2000 Feb 11; 57(2):385-400. PubMed ID: 10652015
    [Abstract] [Full Text] [Related]

  • 37. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis.
    van Bruggen MC, Kramers C, Walgreen B, Elema JD, Kallenberg CG, van den Born J, Smeenk RJ, Assmann KJ, Muller S, Monestier M, Berden JH.
    Nephrol Dial Transplant; 1997 Jan 11; 12(1):57-66. PubMed ID: 9027774
    [Abstract] [Full Text] [Related]

  • 38. Nidogen and heparan sulfate proteoglycan: detection of newly isolated basement membrane components in normal and epidermolysis bullosa skin.
    Caughman SW, Krieg T, Timpl R, Hintner H, Katz SI.
    J Invest Dermatol; 1987 Dec 11; 89(6):547-50. PubMed ID: 2960746
    [Abstract] [Full Text] [Related]

  • 39. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate.
    Ofosu-Appiah W, Sfeir G, Viti D, Burashnikova E.
    Cell Immunol; 1998 Jan 10; 183(1):22-31. PubMed ID: 9578716
    [Abstract] [Full Text] [Related]

  • 40. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K.
    Am J Pathol; 1994 Feb 10; 144(2):337-47. PubMed ID: 8311117
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.